首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1448544

全球羊膜穿刺針市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Amniocentesis Needle Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年02月01日 | 出版商:

Value Market Research | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球羊膜穿刺針市場的市場規模將從 2023 年的 177.22 萬美元達到近 296.12 萬美元，2024-2032 年研究期間的CAGR為 5.87%。

羊膜穿刺針是一種用於產前診斷程序的醫療器械。此手術通常在懷孕中期進行，需要抽取胎兒周圍的少量羊水。這種液體含有可以提供有價值的遺傳訊息的細胞，有助於檢測染色體異常和遺傳性疾病。在超音波引導下將羊膜穿刺針小心地導入羊膜囊，收集的樣本進行實驗室分析。雖然提供了寶貴的見解，但該手術出現併發症的風險很小，強調了仔細醫療考慮的重要性。

市場動態

羊膜穿刺針市場主要受到母親年齡增加、遺傳性疾病盛行率上升以及產前診斷進步等相關因素的推動。由於產婦年齡是染色體異常的重要危險因素，延遲懷孕的趨勢增加了對羊膜穿刺的需求。產前篩檢意識的不斷增強以及對遺傳性疾病早期檢測的渴望推動了市場的成長。針設計的技術進步，例如非侵入性針的開發和超音波引導的使用，提高了羊膜穿刺術的安全性和準確性。此外，對預防性醫療保健的日益重視和非侵入性產前檢測選項的可用性有助於整體市場的擴張。旨在提高精度並降低羊膜穿刺術相關風險的持續研發工作進一步推動了市場的發展。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球羊膜穿刺針市場的各個細分市場進行了包容性評估。羊膜穿刺針產業的成長和趨勢為本研究提供了整體方法。

市場區隔

羊膜穿刺針市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

依產品類型

100 至 150 毫米
小於100毫米
大於150毫米

按程式

羊膜穿刺程序
羊膜縮小手術
胎兒輸血
羊膜腔灌注程序
臍帶穿刺程序

按最終用途

醫院
診斷中心
診所
其他最終用戶

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲羊膜穿刺針市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。羊膜穿刺針市場的主要參與者包括Argon Medical Devices Inc.、AngioDynamics Inc.、Becton Dickinson and Company、Biopsybell Srl、Cook Medical、CooperSurgical, Inc.、Integra LifeSciences Corporation、Laboratoire CCD、Medline Industries, Inc.、Medtronic plc 。，RI.MOS。 Srl、Rocket Medical plc.、Smiths Group plc.、Teleflex Incorporated、Terumo Corporation。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：羊膜穿刺針公司的競爭格局

羊膜穿刺針市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Argon Medical Devices Inc.

公司簡介
公司收入
產品
最近的發展

AngioDynamics Inc.

公司簡介
公司收入
產品
最近的發展

Becton Dickinson and Company

公司簡介
公司收入
產品
最近的發展

Biopsybell Srl

公司簡介
公司收入
產品
最近的發展

Cook Medical

公司簡介
公司收入
產品
最近的發展

CooperSurgical Inc.

公司簡介
公司收入
產品
最近的發展

Integra LifeSciences Corporation

公司簡介
公司收入
產品
最近的發展

Laboratoire CCD

公司簡介
公司收入
產品
最近的發展

Medline Industries Inc.

公司簡介
公司收入
產品
最近的發展

Medtronic plc

公司簡介
公司收入
產品
最近的發展

RI.MOS. Srl

公司簡介
公司收入
產品
最近的發展

Rocket Medical plc.

公司簡介
公司收入
產品
最近的發展

Smiths Group plc

公司簡介
公司收入
產品
最近的發展

Teleflex Incorporated

公司簡介
公司收入
產品
最近的發展

Terumo Corporation

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113802

The global demand for Amniocentesis Needle Market is presumed to reach the market size of nearly USD 296.12 MN by 2032 from USD 177.22 MN in 2023 with a CAGR of 5.87% under the study period 2024 - 2032.

An amniocentesis needle is a medical instrument used in prenatal diagnostic procedures. This procedure is typically conducted in the second trimester of pregnancy and entails extracting a small quantity of amniotic fluid that surrounds the fetus. This fluid contains cells that can provide valuable genetic information, aiding in the detection of chromosomal abnormalities and genetic disorders. The amniocentesis needle is carefully guided into the amniotic sac under ultrasound guidance, and the collected sample undergoes laboratory analysis. While offering valuable insights, the procedure carries a small risk of complications, emphasizing the importance of careful medical consideration.

MARKET DYNAMICS

The Amniocentesis needle market is primarily driven by factors related to the increasing maternal age, rising prevalence of genetic disorders, and advancements in prenatal diagnostics. As maternal age is a significant risk factor for chromosomal abnormalities, the trend toward delayed pregnancies contributes to the demand for amniocentesis procedures. The expanding awareness of prenatal screening and the desire for early detection of genetic disorders propel market growth. Technological advancements in needle design, such as the development of atraumatic needles and the use of ultrasound guidance, enhance the safety and accuracy of amniocentesis procedures. Moreover, the growing emphasis on preventive healthcare and the availability of non-invasive prenatal testing options contribute to the overall market expansion. The continuous research and development efforts aimed at improving precision and reducing the risks associated with amniocentesis further drive the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of amniocentesis needle. The growth and trends of amniocentesis needle industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the amniocentesis needle market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

100 To 150 Mm
Smaller Than 100 Mm
Larger Than 150 Mm

By Procedure

Amniocentesis Procedures
Amnioreduction Procedures
Fetal Blood Transfusions
Amnioinfusion Procedures
Cordocentesis Procedures

By End-Use

Hospitals
Diagnostics Centers
Clinics
Other End-Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Amniocentesis Needle market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Amniocentesis Needle market include Argon Medical Devices Inc., AngioDynamics Inc., Becton Dickinson and Company, Biopsybell Srl, Cook Medical, CooperSurgical, Inc., Integra LifeSciences Corporation, Laboratoire CCD, Medline Industries, Inc., Medtronic plc, RI.MOS. Srl, Rocket Medical plc., Smiths Group plc, Teleflex Incorporated, Terumo Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . AMNIOCENTESIS NEEDLE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Procedure
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL AMNIOCENTESIS NEEDLE MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 100 To 150 Mm Historic and Forecast Sales by Regions
5.5 Smaller Than 100 Mm Historic and Forecast Sales by Regions
5.6 Larger Than 150 Mm Historic and Forecast Sales by Regions

6 . GLOBAL AMNIOCENTESIS NEEDLE MARKET ANALYSIS BY PROCEDURE

6.1 Overview by Procedure
6.2 Historical and Forecast Data
6.3 Analysis by Procedure
6.4 Amniocentesis Procedures Historic and Forecast Sales by Regions
6.5 Amnioreduction Procedures Historic and Forecast Sales by Regions
6.6 Fetal Blood Transfusions Historic and Forecast Sales by Regions
6.7 Amnioinfusion Procedures Historic and Forecast Sales by Regions
6.8 Cordocentesis Procedures Historic and Forecast Sales by Regions

7 . GLOBAL AMNIOCENTESIS NEEDLE MARKET ANALYSIS BY END-USE

7.1 Overview by End-Use
7.2 Historical and Forecast Data
7.3 Analysis by End-Use
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Diagnostics Centers Historic and Forecast Sales by Regions
7.6 Clinics Historic and Forecast Sales by Regions
7.7 Other End-Users Historic and Forecast Sales by Regions

8 . GLOBAL AMNIOCENTESIS NEEDLE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE AMNIOCENTESIS NEEDLE COMPANIES

9.1. Amniocentesis Needle Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF AMNIOCENTESIS NEEDLE INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Argon Medical Devices Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. AngioDynamics Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Becton Dickinson and Company
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Biopsybell Srl
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Cook Medical
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. CooperSurgical Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Integra LifeSciences Corporation
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Laboratoire CCD
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Medline Industries Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Medtronic plc
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. RI.MOS. Srl
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Rocket Medical plc.
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. Smiths Group plc
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. Teleflex Incorporated
- 10.16.1. Company Overview
- 10.16.2. Company Revenue
- 10.16.3. Products
- 10.16.4. Recent Developments
10.17. Terumo Corporation
- 10.17.1. Company Overview
- 10.17.2. Company Revenue
- 10.17.3. Products
- 10.17.4. Recent Developments